- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glucose Infusion in Spain
Total 668 results
-
Medtronic DiabetesRecruitingType 1 DiabetesUnited States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
-
Solvay PharmaceuticalsCompletedHypertension | Type 2 DiabetesFrance, Canada, Denmark, Germany, Italy, Norway, Spain, Sweden, United Kingdom
-
Sankyo Pharma GmbhCompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria | Renal DiseasePoland, Spain, Estonia, Czech Republic, Germany, Slovakia, Netherlands
-
SanofiCompletedDiabetes Mellitus, Type 2Germany, Spain, Brazil, France, Ireland, Romania, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2Italy, Ireland, Spain, Greece, Finland, Romania, Brazil, United Kingdom, France, Switzerland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Brazil, India, Puerto Rico, Romania, Poland, Germany, Croatia, Korea, Republic of, Mexico, United Kingdom, South Africa, Spain, Canada, Argentina, Czech Republic, Finland, France, Slovakia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
Eli Lilly and CompanyCompletedDiabetes Mellitus Type 2Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Spain, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Slovakia, Spain, France, Hungary, Mexico, Russian Federation, Turkey, Czechia, Greece, Argentina
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Mount Sinai Hospital, CanadaCambridge University Hospitals NHS Foundation Trust; University of Cambridge; Jaeb Center for Health Research and other collaboratorsCompletedType 1 Diabetics Who Are Pregnant or Planning PregnancyCanada, United Kingdom, Spain, United States, Ireland, Italy
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Spain, Switzerland, Argentina, Finland, Hungary, Russian Federation, Slovenia, Slovakia
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt, United Kingdom, Turkey, Lebanon, Russian Federation, Tunisia, Malaysia, Germany, Spain, Saudi Arabia, Denmark, Indonesia, Jordan, Kuwait, Singapore, United Arab Emirates
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
AstraZenecaCompletedDiabetesSpain, United Kingdom, Belgium, Portugal, Greece, Luxembourg
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael, Poland, Switzerland, Argentina, India, Malaysia, South Africa, Taiwan, Finland, France, Turkey, Croatia, Italy, Bulgaria, Romania, Australia, Thailand, Greece, Brazil, Spain, Korea, Republic of, Czech Republic, Philippines
-
Fractyl Health Inc.RecruitingType 2 DiabetesUnited States, Ireland, United Kingdom, Belgium, Italy, Netherlands, Switzerland, Spain, France
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Spain, India, Belgium, Argentina, Austria, France, Mexico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Spain, Canada, Austria, Latvia, Slovakia, United Kingdom, Chile, Mexico, Netherlands
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Estonia, Germany, Latvia, Spain, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, United Kingdom, Canada, Spain, Denmark, Austria, Serbia, South Africa, Sweden, Italy, Bulgaria, Germany, Malaysia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Canada, Hungary, India, Spain, Puerto Rico
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
TheracosCompletedType 2 Diabetes MellitusUnited States, France, Spain, Japan
-
Diamyd Medical ABRecruitingType 1 Diabetes MellitusCzechia, Spain, United States, Hungary, Netherlands, Estonia, Germany, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Israel, Italy, Russian Federation, United Kingdom, Denmark, Austria, Serbia, Canada, Croatia, Australia, Greece, Ireland, Brazil, Spain, Argentina
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Chile, Colombia, Germany, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Turkey
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Netherlands, Austria, Spain, France, Germany, Ireland, Switzerland, Finland
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Spain, United States, Germany, Czechia, Hungary, Poland
-
Lexicon PharmaceuticalsSanofiCompletedType 1 Diabetes MellitusIsrael, Italy, Spain, Bulgaria, Hungary, Poland, Slovakia, United Kingdom, Austria, Belgium, France, Germany, Lithuania, Netherlands, Romania, Sweden, Switzerland
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Denmark, Sweden, Austria, Germany, Macedonia, The Former Yugoslav Republic of, Slovenia, France, Switzerland, Norway, Spain, Ireland, Finland, Romania
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Belgium, Brazil, Canada, Czech Republic, Finland, Germany, Greece, Italy, Korea, Republic of, Mexico, Netherlands, Norway, Peru, Russian Federation, Slovakia, Spain, Taiwan
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIsrael, Italy, United Kingdom, Denmark, Spain, Singapore, Taiwan, Germany, France, Hong Kong, Brazil
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Spain, Germany, Puerto Rico, Austria